At 14 days there should be quite some symptom resolution, but again it depends on the type of allergy the child presented with in the first place. If the child presented with immediate-type symptoms (eg, angioedema, vomiting, rapid onset eczema) to cow’s milk/dairy then they should have seen symptom resolution by now (commonly takes 3-5 days).2 However, when the child’s symptoms were delayed (eg, presented with exacerbations of eczema or rectal bleeding) to cow’s milk/dairy then it may take up to 14 days2 or longer1. A diagnosis of eosinophilic oesophagitis or severe atopic dermatitis (AD), for example, can take up to 6 weeks to resolve.3,4
Be aware also that improvements in gastrointestinal, skin and respiratory symptoms may take as long as 6 weeks when using an eHF.5,6 Infants with significant gastrointestinal symptoms with no improvement after the recommended exclusion period on the eHF may benefit from an AAF. This is because there may be residual allergenicity in some eHFs which trigger low grade reactions in sensitive infants.2 This is particularly true in those with multiple sensitisations to many foods.2 However, if there is still no improvement in symptoms on the AAF, then CMPA is unlikely.1 In general, children taking an AAF are expected to have resolutions of symptoms by around 14 days.7 Although AAFs are generally reserved for severe cases of CMPA.
So, if the child’s symptoms have not resolved after 14 days that does not mean that the elimination diet or product you are using is not working, it very much depends on the allergic reaction and product selected.
1. Vandenplas Y, et al. An ESPGHAN position paper. 2023. https://www.espghan.org/dam/jcr:7100468b-c6df-48bc-a566-6b13c427e756/CMA%20ESPGHAN%202022_V31.pdf;
2. Koletzko S, et al. J Pediatr Gastroenterol Nutr. 2012;55(2):221-9.
3. Vandenplas Y, et al. J Asthma Allergy. 2021;14:1243-1256.
4. Katta R, & Schlichte M. J Clin Aesthet Dermatol. 2014;7(3):30-6.
5. Lemale J, et al. Nutrients. 2022;14(6):1203.
6. Wilsey MJ, et al. Nutrients. 2023;15(7):1677.
7. Vanderhoof J, et al. JPGN. 2016;63(5):531 – 533.